413 related articles for article (PubMed ID: 15936469)
1. Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study.
Pozzilli P; Manfrini S; Buzzetti R; Lampeter E; Leeuw ID; Iafusco D; Prisco M; Ionescu-Tirgoviste C; Kolouskovà S; Linn T; Ludvigsson J; Madàcsy L; Mrozikiewicz AS; Mrozikiewicz PM; Podar T; Vavrinec J; Vialettes B; Visalli N; Yilmaz T; Browne PD;
Diabetes Res Clin Pract; 2005 Jun; 68(3):258-64. PubMed ID: 15936469
[TBL] [Abstract][Full Text] [Related]
2. Normal weight promotes remission and low number of islet antibodies prolong the duration of remission in Type 1 diabetes.
Schölin A; Törn C; Nyström L; Berne C; Arnqvist H; Blohmé G; Bolinder J; Eriksson JW; Kockum I; Landin-Olsson M; Ostman J; Karlsson FA; Sundkvist G; Björk E
Diabet Med; 2004 May; 21(5):447-55. PubMed ID: 15089789
[TBL] [Abstract][Full Text] [Related]
3. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
[TBL] [Abstract][Full Text] [Related]
4. Smoking and other factors associated with short-term partial remission of Type 1 diabetes in adults.
Pilacinski S; Adler AI; Zozulinska-Ziolkiewicz DA; Gawrecki A; Wierusz-Wysocka B
Diabet Med; 2012 Apr; 29(4):464-9. PubMed ID: 21978224
[TBL] [Abstract][Full Text] [Related]
5. Effects of methylprednisolone pulse therapy on insulin injections in patients with insulin-dependent diabetes mellitus.
Satman I; Fiçicioğlu C; Karşidağ K; Yilmaz T; Dinçdağ N; Koca F; Odabaşi F; Aydin A; Devrim S; Haktan M
Turk J Pediatr; 1996; 38(4):419-29. PubMed ID: 8993171
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of an intensive treatment education program for type 1 diabetes in a group of adolescents. A two year follow up].
Krochik AG; Mazza CS; Araujo MB; Kovalskys I; Ozuna B; Assad D; Coppola L; Domenech I; Lahera E; Zufriategui Z; Gagliardino JJ
Medicina (B Aires); 2004; 64(2):107-12. PubMed ID: 15628295
[TBL] [Abstract][Full Text] [Related]
7. A longitudinal observational study of insulin therapy and glycaemic control in Scottish children with Type 1 diabetes: DIABAUD 3.
Scottish Study Group for the Care of the Young with Diabetes
Diabet Med; 2006 Nov; 23(11):1216-21. PubMed ID: 17054598
[TBL] [Abstract][Full Text] [Related]
8. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
[TBL] [Abstract][Full Text] [Related]
9. Parental preference of prandial insulin aspart compared with preprandial human insulin in a basal-bolus scheme with NPH insulin in a 12-wk crossover study of preschool children with type 1 diabetes.
Danne T; Råstam J; Odendahl R; Näke A; Schimmel U; Szczepanski R; Moeller J; Deiss D
Pediatr Diabetes; 2007 Oct; 8(5):278-85. PubMed ID: 17850471
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of conversion from bedtime NPH insulin to morning insulin glargine in type 2 diabetic patients on basal-prandial insulin therapy.
Yokoyama H; Tada J; Kamikawa F; Kanno S; Yokota Y; Kuramitsu M
Diabetes Res Clin Pract; 2006 Jul; 73(1):35-40. PubMed ID: 16513202
[TBL] [Abstract][Full Text] [Related]
11. Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?
Schatz D; Cuthbertson D; Atkinson M; Salzler MC; Winter W; Muir A; Silverstein J; Cook R; Maclaren N; She JX; Greenbaum C; Krischer J
Pediatr Diabetes; 2004 Jun; 5(2):72-9. PubMed ID: 15189492
[TBL] [Abstract][Full Text] [Related]
12. Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes.
Päivärinta M; Tapanainen P; Veijola R
Pediatr Diabetes; 2008 Jun; 9(3 Pt 2):83-90. PubMed ID: 18221431
[TBL] [Abstract][Full Text] [Related]
13. Semilente-insulin at bedtime is superior to NPH-insulin for the suppression of the dawn-phenomenon in adolescents with type-I-diabetes.
Holl RW; Teller WM; Heinze E
Exp Clin Endocrinol Diabetes; 1996; 104(5):360-4. PubMed ID: 8957270
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort.
Dornhorst A; Lüddeke HJ; Sreenan S; Koenen C; Hansen JB; Tsur A; Landstedt-Hallin L
Int J Clin Pract; 2007 Mar; 61(3):523-8. PubMed ID: 17313628
[TBL] [Abstract][Full Text] [Related]
15. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
Hermansen K; Dornhorst A; Sreenan S
Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940
[TBL] [Abstract][Full Text] [Related]
16. Prevailing therapeutic regimes and predictive factors for prandial insulin substitution in 26 687 children and adolescents with Type 1 diabetes in Germany and Austria.
Knerr I; Hofer SE; Holterhus PM; Näke A; Rosenbauer J; Weitzel D; Wolf J; Holl RW
Diabet Med; 2007 Dec; 24(12):1478-81. PubMed ID: 17971184
[TBL] [Abstract][Full Text] [Related]
17. Remission of hyperglycemia following intensive insulin therapy in newly diagnosed type 2 diabetic patients: a long-term follow-up study.
Xu W; Li YB; Deng WP; Hao YT; Weng JP
Chin Med J (Engl); 2009 Nov; 122(21):2554-9. PubMed ID: 19951569
[TBL] [Abstract][Full Text] [Related]
18. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
[TBL] [Abstract][Full Text] [Related]
19. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
[TBL] [Abstract][Full Text] [Related]
20. Glycaemic control with modified intensive insulin injections (MII) using insulin pens and premixed insulin in children with type-1 diabetes: a randomized controlled trial.
Soliman AT; Omar M; Rizk MM; El Awwa A; AlGhobashy FM
J Trop Pediatr; 2006 Aug; 52(4):276-81. PubMed ID: 16410276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
